A novel embolization-on-a-chip model allows testing various embolic agent classes to treat liver cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 20-Nov-2025 18:11 ET (20-Nov-2025 23:11 GMT/UTC)
Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel platform reflects the microenvironment of liver tumors, particularly a functional and perfusable microvasculature that can be embolized. This powerful in vitro tool aligns with the National Institutes of Health (NIH) efforts to reduce animal testing and promote alternative methods, including microfluidic devices that mimic human organs.
The launch is a significant milestone in INSEAD’s innovation journey. It showcases the school’s ability to translate academic insight into real-world impact, taking an internally generated concept and successfully commercialising it through collaboration with a leading global partner.
A research team has developed Spotibot, a deep learning–powered application available on both web and mobile platforms, designed to automatically detect and measure Botrytis lesions on rose petals.
A research team introduces the In-Media Plant PET Root Imaging System (IMP2RIS), a novel tool that enables real-time, non-invasive, three-dimensional imaging of symbiotic nitrogen fixation (SNF) in soybean roots grown in soil-like media.
Microplastics are tiny, plastic fragments — many too small to see — found in the air, soil and water. Measuring their abundance in nature can direct cleanup resources, but current detection methods are slow, expensive or highly technical. Now, researchers publishing in ACS Sensors have developed a living sensor that attaches to plastic and produces green fluorescence. In an initial test on real-world water samples, the biosensor could easily detect environmentally relevant levels of microplastics.